SC 13D/A

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D

(Amendment No. 3)

Under the Securities Exchange Act of 1934*

BioFuel Energy Corp.

(Name of Company)

Common Stock, par value $0.01 per share

(Title of Class of Securities)

09064Y109

(CUSIP Number of Class of Securities)

Daniel S. Loeb

Third Point LLC

390 Park Avenue

New York, NY 10022

(212) 224-7400

(Name, Address and Telephone Number of Person

Authorized to Receive Notices and Communications)

Copies to:

Michael A. Schwartz, Esq.

Willkie Farr & Gallagher LLP

787 Seventh Avenue

New York, NY  10019-6099

(212) 728-8000

September 24, 2010

(Date of Event which Requires

Filing of this Schedule)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box:  o

NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits.  See Rule 240.13d-7 for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person's  initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

SCHEDULE 13D

CUSIP No.      09064Y109 Page 2 of 14 Pages

1	NAME OF REPORTING PERSON Third Point LLC
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP(a)  o                                                                                                                                               0;                                                                                                           (b)  x
3	SEC USE ONLY
4	SOURCE OF FUNDS* AF
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)                                                                  o
6	CITIZENSHIP OR PLACE OF ORGANIZATION Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		7	SOLE VOTING POWER 0
		8	SHARED VOTING POWER 5,578,800
		9	SOLE DISPOSITIVE POWER 0
		10	SHARED DISPOSITIVE POWER 5,578,800
11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON 5,578,800
12	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*                                                                                          o
13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 21.9%
14	TYPE OF REPORTING PERSON* OO

SCHEDULE 13D

CUSIP No.       09064Y109 Page 3 of 14 Pages

1	NAME OF REPORTING PERSON Daniel S. Loeb
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP                                                         (a)  o                                                          (b)   x
3	SEC USE ONLY
4	SOURCE OF FUNDS* AF
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)                                                                 o
6	CITIZENSHIP OR PLACE OF ORGANIZATION United States
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		7	SOLE VOTING POWER 224,484
		8	SHARED VOTING POWER 5,578,800
		9	SOLE DISPOSITIVE POWER 224,484
		10	SHARED DISPOSITIVE POWER 5,578,800
11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON 5,803,284
12	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*                                                                                         o
13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 22.8%
14	TYPE OF REPORTING PERSON* IN

SCHEDULE 13D

CUSIP No.       09064Y109 Page 4 of 14 Pages

1	NAME OF REPORTING PERSON Third Point Partners LP
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP(a)   o                                                            (b)   x
3	SEC USE ONLY
4	SOURCE OF FUNDS* AF
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)                                                                  o
6	CITIZENSHIP OR PLACE OF ORGANIZATION Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		7	SOLE VOTING POWER 0
		8	SHARED VOTING POWER 2,867,782
		9	SOLE DISPOSITIVE POWER 0
		10	SHARED DISPOSITIVE POWER 2,867,782
11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON 2,867,782
12	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*                                                                                          o
13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 11.3%
14	TYPE OF REPORTING PERSON* PN

SCHEDULE 13D

CUSIP No.       09064Y109 Page 5 of 14 Pages

1	NAME OF REPORTING PERSON Third Point Partners Qualified LP
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP(a)  o                                                                   (b)  x
3	SEC USE ONLY
4	SOURCE OF FUNDS* AF
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)                                                                          o
6	CITIZENSHIP OR PLACE OF ORGANIZATION Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		7	SOLE VOTING POWER 0
		8	SHARED VOTING POWER 1,808,018
		9	SOLE DISPOSITIVE POWER 0
		10	SHARED DISPOSITIVE POWER 1,808,018
11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON 1,808,018
12	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*                                                                                                  o
13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 7.1%
14	TYPE OF REPORTING PERSON* PN

This Amendment No. 3 to Schedule 13D (this “Amendment No. 3”) is being filed with respect to the Class A common stock, par value $0.01 per share (the “Common Stock”), of BioFuel Energy Corp., a Delaware corporation (the "Company"), to amend the Schedule 13D filed on June 25, 2007 (as amended by Amendment No. 1 thereto filed on December 31, 2008, Amendment No. 2 thereto filed on April 3, 2009 and this Amendment No. 3, the “Schedule 13D”).  This Amendment No. 3 is being filed on behalf of Third Point LLC, a Delaware limited liability company (the “Management Company"), Daniel S. Loeb, an individual (“Mr. Loeb"), Third Point Partners LP, a Delaware limited partnership (“Third Point Partners”), and Third Point Partners Qualified LP, a Delaware limited partnership (“T hird Point Partners Qualified”, and together with the Management Company, Mr. Loeb and Third Point Partners, the “Reporting Persons”).

The Management Company is the investment manager or adviser to a variety of hedge funds and managed accounts (such funds and accounts, collectively, including but not limited to Third Point Partners and Third Point Partners Qualified, the "Funds").  The Management Company and Mr. Loeb may be deemed to have beneficial ownership over shares of Common Stock directly beneficially owned by the Funds, by virtue of the authority granted to them by the Funds to vote and to dispose of the securities held by the Funds, including the Common Stock.

This Amendment No. 3 is being filed in connection with a plan or proposal concerning Third Point Loan LLC, an affiliate of the Reporting Persons (the “Affiliate”), that could result in the acquisition by the Reporting Persons of additional securities of the Issuer.

The Reporting Persons no longer maintain contact with Lawrence J. Bernstein, previously one of the joint filers of the Schedule 13D, with respect to their investments in the Company.  Accordingly, Mr. Bernstein is no longer a joint filer with the Reporting Persons of the Schedule 13D.

Item 4.                      Purpose of Transaction.

Item 4 of the Schedule 13D is hereby amended to add the following:

After engaging in discussions with the Issuer, the Reporting Persons have entered into an agreement (the “Loan Agreement”) with the Issuer regarding several transactions involving securities of the Issuer. The following is a summary of the Loan Agreement and the related transactions. Under the Loan Agreement, the Affiliate and certain other stockholders of the Issuer (together with the Reporting Persons, the “Lenders”) have agreed to provide the Issuer with a short-term bridge loan of $19,420,620 (the “Bridge Loan”), the proceeds of which are to be used to repay the working capital facility of subsidiaries of the Issuer under their senior credit facility and pay down certain other indebtedness of the Issuer and its subsidiaries.  The Loan Agreem ent provides that the Bridge Loan will bear interest at a rate of 12.5%, have a maturity date of March 24, 2011 and be secured by the Issuer’s pledge of its equity interest in one of the Issuer’s subsidiaries, BioFuel Energy, LLC.  In consideration of the Bridge Loan, the Loan Agreement provides for payment by the Issuer of a 4% funding fee to the Lenders.  In the event the Bridge Loan is not paid off by the maturity date, the Loan Agreement provides that the Lenders, in addition to all other rights and remedies under the Bridge Loan, would be issued warrants (the “Warrants”) exercisable for an aggregate of 15% of the Issuer’s equity capitalization on a fully-diluted basis at an exercise price of $0.01 per share.

In connection with the Bridge Loan, the Issuer and the Lenders entered into a Rights Offering Letter Agreement, dated September 24, 2010 (the “Rights Offering Letter”).  Under the Rights Offering Letter, the Issuer has agreed to use its commercially reasonable best efforts to conduct a registered offering for rights to purchase shares of preferred stock of the Issuer (the “Rights Offering”).  Under the Rights Offering Letter, the Issuer has committed to use its commercially reasonable best efforts to (i) file a Registration Statement on Form S-3 (the “Registration Statement”) with the Securities and Exchange Commission (the “Commission”) on or before October 18, 2010 and (ii) cause such Registration Statement to be dec lared effective on or before January 24, 2011 and to remain effective throughout the entire offering period without interruption.

In the Rights Offering, the Issuer would distribute, at no charge to each of the Issuer’s existing holders of Common Stock, rights (the “Rights”) to purchase up to an aggregate of 4,000,000 shares of Series A Convertible Preferred Stock (“Series A Convertible Preferred Stock”), at a per share offering price equal to $10.00 per share (the “Per Preferred Share Purchase Price”).  Each Right would entitle the holder thereof to acquire, at a price equal to the Rights Price, a number of shares of Series A Convertible Preferred Stock equal to the fraction determined by dividing 4,000,000 by the number of Rights offered in the Rights Offering. The number of Rights offered in the Rights Offer ing is to be determined by dividing the offering size of the Rights Offering by the Rights Price. The offering size of the Rights Offering is anticipated to be an amount equal to $40,000,000, and is to be the amount sufficient to repay all amounts owed (whether in whole or in part), including accrued and unpaid interest, under the Bridge Loan and the Mezzanine Loan Agreement (as defined under the Loan Agreement) and to make the Cargill Payment (as defined below), including certain fees and expenses incurred in connection with the Rights Offering.  The Rights Offering Letter provides that each share of Series A Convertible Preferred Stock issued in the Rights Offering will be convertible into that number of shares of Common Stock equal to the quotient obtained by dividing the Per Preferred Share Purchase Price by the lesser of (A) a dollar amount equal to 25% of the average per share closing price of the Common Stock for the five (5) trading days immediately following the initial filing of the Regis tration Statement and (B) $0.75 (such price being the “Rights Price”).  The proceeds of the Rights Offering would be used to (i) first, pay off the Bridge Loan; (ii) second, pay off other indebtedness owed to the Lenders; (iii) third, pay down certain indebtedness owed to Cargill, Incorporated and its affiliates (the “Cargill Payment”); and (iv) the remainder, if any, for general corporate purposes.

The Rights Offering contemplates all holders of the Issuer’s Common Stock being eligible to participate in the Rights Offering pro rata based on each such holder’s ownership of Common Stock at the time of the Rights Offering.  The Rights Offering Letter provides the Lenders with registration rights for the shares of Common Stock issued upon conversion of the Series A Convertible Preferred Stock.

Under the Rights Offering Letter, the Lenders have agreed to (i) participate in the Rights Offering for their full pro rata share of Rights offered to them (the “Basic Commitment”) and (ii) subject to certain terms, conditions and limitations, commit to purchase all of the additional shares of Series A Convertible Preferred Stock not otherwise sold in the Rights Offering (the “Backstop Commitment”).  Notwithstanding the foregoing, the Rights Offering Letter provides for (i) the Lenders having the ability to reduce the number of shares of Series A Convertible Preferred Stock that the Lenders would otherwise be obligated to purchase pursuant to the Backstop Commitment and/or the Basic Commitment, or (ii) the Issuer having the ability to reduce the aggregate n umber of shares of Series A Convertible Preferred Stock that are offered in the Rights Offering, in the event the Lenders determine, in their sole discretion, but after consultation with the Issuer, that consummation of the Rights Offering, the Basic Commitment and/or the Backstop Commitment would result in adverse tax, legal or regulatory consequences to the Issuer and/or any Lender (“Adverse Consequences”).  In the event of a backstop reduction, the Rights Offering Letter contemplates the Rights Offering nonetheless proceeding and the parties using their respective commercially reasonable best efforts to structure and consummate an alternative transaction to take the place of the issuance of the shortfall amount.  In consideration of the Backstop Commitment, the Issuer has agreed to pay to the Lenders their pro rata portion of an aggregate amount in cash equal to 4% of the total purchase price for the Series A Convertible Preferred Stock offered in the Rights Offering to eli gible holders of Common Stock other than the Lenders.

The Rights Offering Letter also provides that, under certain circumstances, the Issuer may terminate the Rights Offering, in which case the Reporting Persons may be entitled to their pro rata share of a break-up fee of $350,000.

The Loan Agreement provides for (i) the waiver by the Issuer’s management of all change of control benefits that would otherwise arise as a result of the transactions contemplated by the Agreement, (ii) payment or reimbursement of the expenses incurred by the Reporting Persons in connection with the transactions contemplated by the Loan Agreement and (iii) indemnification for the benefit of the Reporting Persons.

The Affiliate has entered into a Voting Agreement (the “Voting Agreement”) that, among other things, requires the Affiliate to cast its votes in favor of any proposal by the Issuer to amend its restated certificate so as to increase the number of authorized but unissued shares of Common Stock up to an amount of shares sufficient to enable the Issuer to convert all Series A Convertible Preferred Stock issuable pursuant to the (i) Rights Offering, (ii) the Warrants and (iii) each other transaction contemplated by the Agreement, including the Cargill Payment, which shares of Common Stock shall rank pari passu with the existing shares of Common Stock.

In addition, consistent with the Reporting Persons’ investment purposes, each Reporting Person, at any time and from time to time, may acquire additional securities of the Issuer or dispose of any or all of its securities of the Issuer depending upon an ongoing evaluation of the investment in such securities, prevailing market conditions, other investment opportunities, liquidity requirements of the Reporting Persons and/or other investment considerations. No Reporting Person has made a determination regarding a maximum or minimum number of securities of the Issuer that it may hold at any point in time.

Also, consistent with their investment purpose, the Reporting Persons have engaged in, and intend to continue to engage in, communications with one or more of the Issuer’s stockholders, officers and/or members of the board of directors relating to topics including, but not limited to, the operations of the Issuer.

Certain other stockholders of the Issuer, each of which is affiliated with Greenlight Capital, L.L.C. (collectively, “Greenlight”), have entered into agreements to participate in the Bridge Loan and/or the Rights Offering.  According to Amendment No. 3 to Schedule 13D filed on behalf of Greenlight with the Commission on September 27, 2010, Greenlight beneficially owned 11,853,500 shares of Common Stock, representing approximately 46.6% of the issued and outstanding Common Stock of the Issuer.  By virtue of the Reporting Persons and Greenlight, and Greenlight’s participation in the Bridge Loan and/or the Rights Offering, such parties may be deemed to have formed a “group” within the meaning of Section 13(d) under the Act.  If the Re porting Persons and Greenlight are deemed to have formed a group, the group may be deemed to beneficially own, collectively, approximately 17,656,784 shares of Common Stock, representing approximately 69.3% of the issued and outstanding shares of Common Stock of the Issuer based on the number of outstanding shares of Common Stock reported by the Issuer in its Quarterly Report on Form 10-Q for the period ended June 30, 2010 filed with the Commission on August 16, 2010.  Although, as indicated above, the Reporting Persons may be deemed members of a group within the meaning of Section 13(d) of the Act with Greenlight, the Reporting Persons expressly disclaim membership in a group with Greenlight or any other person.

Item 5.                      Interest in Securities of the Company.

Item 5 of the Schedule 13D is hereby amended to add the following:

The information contained in Item 4 of this Amendment No. 3 is incorporated herein by reference.

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Company.

Item 6 of the Schedule 13D is hereby amended to add the following:

The information contained in Item 4 of this Amendment No. 3 is incorporated herein by reference.

Item 7.               Material to be Filed as Exhibits

99.9 Power of Attorney granted by Daniel S. Loeb in favor of James P. Gallagher, William Song, Joshua L. Targoff and Bruce Wilson, dated January 5, 2009, was previously filed with the SEC on January 7, 2009 as an exhibit to Amendment No. 3 to Schedule 13G filed by Third Point LLC, Daniel S. Loeb, Third Point Offshore Fund, Ltd., Third Point Offshore Master Fund, L.P. and Third Point Advisors II L.L.C. with respect to Depomed, Inc. and that is incorporated herein by reference.

99.10 Amended and Restated Joint Filing Agreement, dated as of September 27, 2010, by and among the Reporting Persons.

99.11 Form of Warrant to be issued by the Issuer.

99.12 Loan Agreement dated as of September 24, 2010, by and among the Issuer, Greenlight Capital, LP, Greenlight Capital Qualified, LP, Greenlight Capital (Gold), LP, Greenlight Capital Offshore Partners, Greenlight Capital Offshore Master (Gold), Ltd., Greenlight Reinsurance, Ltd. and Third Point Loan LLC and Greenlight APE, LLC, as administrative agent, as filed by the Issuer on its Form 8-K (the “Form 8-K”), which was filed with the Commission on September 27, 2010 and which is incorporated herein by reference.

99.13 Rights Offering Letter Agreement dated as of September 24, 2010, by and among the Issuer, Greenlight Capital, LP, Greenlight Capital Qualified, LP, Greenlight Capital (Gold), LP, Greenlight Capital Offshore Partners, Greenlight Capital Offshore Master (Gold), Ltd., Greenlight Reinsurance, Ltd. and Third Point Loan LLC, as filed on the Form 8-K and which is incorporated herein by reference.

99.14 Voting Agreement dated as of September 24, 2010 by and between the Issuer and Third Point Loan LLC, as filed on the Form 8-K and which is incorporated herein by reference.

[Signatures on following page]

SIGNATURES

After reasonable inquiry and to the best of our knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.

Dated: September 27, 2010

THIRD POINT LLC

By:           Daniel S. Loeb,

Chief Executive Officer

By:        /s/ William Song                                                       

   Name:                 William Song

   Title:                 Attorney-in-Fact

THIRD POINT PARTNERS LP

By:           Third Point Advisors LLC,

its general partner

By:           Daniel S. Loeb,

Managing Member

By:        /s/ William Song                                                      

   Name:                 William Song

   Title:                 Attorney-in-Fact

THIRD POINT PARTNERS QUALIFIED LP

By: Third Point Advisors LLC,

its general partner

By:           Daniel S. Loeb,

Managing Member

By:        /s/ William Song                                                 

   Name:                 William Song

   Title:                 Attorney-in-Fact

DANIEL S. LOEB

By:        /s/ William Song                                               

   Name:                 William Song

   Title:                 Attorney-in-Fact

[SIGNATURE PAGE TO AMENDMENT NO. 3 TO SCHEDULE 13D WITH RESPECT TO

BIOFUEL ENERGY CORP.]

AMENDED AND RESTATED JOINT FILING AGREEMENT

PURSUANT TO RULE 13d-1(k)(1)

The undersigned acknowledge and agree that the foregoing statement on Schedule 13D is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13D shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements.  The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that it knows or has reason to believe that such information is inaccurate.  This Agreement may be executed in any number of counterparts and all of such counterparts taken together shall const itute one and the same instrument.

Dated: September 27, 2010

THIRD POINT LLC

By:           Daniel S. Loeb,

Chief Executive Officer

By:        /s/ William Song                                                  

   Name:                 William Song

   Title:                 Attorney-in-Fact

THIRD POINT PARTNERS LP

By:           Third Point Advisors LLC, its

general partner

By:           Daniel S. Loeb,

Managing Member

By:        /s/ William Song                                                  

   Name:                 William Song

   Title:                 Attorney-in-Fact

THIRD POINT PARTNERS QUALIFIED LP

By:           Third Point Advisors LLC, its

general partner

By:           Daniel S. Loeb,

Managing Member

By:        /s/ William Song                                         

   Name:                 William Song

   Title:                 Attorney-in-Fact

DANIEL S. LOEB

By:        /s/ William Song                                    

   Name:                 William Song

   Title:                 Attorney-in-Fact

EX-99.11

FORM OF WARRANT

THE SECURITIES REPRESENTED BY THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES REPRESENTED BY THIS WARRANT HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE OFFERED, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL, REASONABLY SATISFACTORY TO THE COMPANY, THAT REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OR APPLICABLE STATE SECURITIES LAWS UNLESS SOLD PURSUANT TO RULE 144 UNDER THE SECURITIES ACT. THE SECURITIES REPRESENTED BY THIS WARRANT ARE SUBJECT TO THE TERMS AND CONDITIONS OF, AND MAY ONLY BE TRANSFERRED IN ACCORDANCE WITH, THE TERMS OF THIS WARRANT.

BIOFUEL ENERGY CORP.

Warrant To Purchase Common Stock

Warrant No.: __________	Number of Shares: __________
Issuance Date: __________ ___, 20___

THIS CERTIFIES THAT, for value received, [lender entity] or its transferees, successors, and assigns (the “Holder”) is entitled to purchase from BioFuel Energy Corp., a Delaware corporation (the “Company”), at any time and from time to time before the Expiration Date (defined below) at the Exercise Price (defined below) ____________ fully paid nonassessable shares of Common Stock (defined below) (the “Warrant Shares”),1 all subject to adjustment and upon the terms and conditions provided herein.

This Warrant is being issued to the Holder pursuant to the Loan Agreement, dated as of September 24, 2010, by and among the Company, the lenders listed as lenders on Schedule 1.1(A) thereto and Greenlight APE, LLC, in its capacity as administrative agent for the lenders (the “Loan Agreement”).  Under the Loan Agreement, the Company is required to issue this warrant to the Holder exercisable for shares of Common Stock, which on an as-converted basis will equal 15% of the Company’s Common Stock on a Fully Diluted Basis as of the date this Warrant is issued, if the Company has not paid off all amounts due under the Loan Agreement on or before the maturity date of such loan, except as otherwise set forth therein.  In connection with the Loan Agre ement, the Company also entered into a Rights Offering Letter Agreement by and among the Company and the other parties party thereto dated as of September 24, 2010 (the “Rights Offering Letter Agreement”) pursuant to which it agreed, subject to the terms and conditions set forth therein, to conduct a registered rights offering to the Company’s existing stockholders of rights to purchase shares of Series A Convertible Preferred Stock.

Section 1.Definitions. The following terms as used in this Warrant have the following meanings:

(a)“Affiliate” of, or a Person “Affiliated” with, a specified Person, is a Person that directly, or indirectly through one or more intermediaries, controls, or is controlled by, or is under common control with, the Person specified.

(b)“Acquiring Entity” has the meaning attributed to it in Section 8(a).

(c)“Business Day” means any day other than a Saturday or Sunday or a legal holiday on which commercial banks are authorized or required to be closed for business in New York, New York.

1 In the event that at the time of issuance, the number of shares of available authorized shares of Common Stock is less than the number of Warrant Shares, the Company shall make up such shortfall by issuing an additional warrant shares of Series A Convertible Preferred Stock (having the terms set forth in the Rights Offering Letter Agreement) for the amount of such shortfall.  Any such warrant for Series A Convertible Preferred Stock will be substantially similar to this form of Warrant, with appropriate changes being made mutatis mutandis to this form of Warrant.

(d)“Change of Control” means (a) the sale, conveyance or disposition of all or substantially all of the assets of the Company (other than pursuant to a joint venture arrangement or other transaction in which the Company, directly or indirectly, receives at least fifty percent (50%) of the voting equity in another entity or a general partnership); (b) the effectuation of a transaction or series of related transactions in which more than fifty percent (50%) of the voting power of the Company is disposed of (other than (i) as a direct result of normal, uncoordinated trading activities in the Common Stock generally or (ii) solely as a result of the disposition by a stoc kholder of the Company to an Affiliate of such stockholder); (c) the consolidation, merger or other business combination of the Company with or into any other entity, immediately following which the prior stockholders of the Company fail to own, directly or indirectly, at least fifty percent (50%) of the voting equity of the surviving entity; (d) a transaction or series of transactions in which any Person or “group” (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) acquires more than fifty percent (50%) of the voting equity of the Company (other than the acquisition by a person or “group” that is an Affiliate of or Affiliated with a person or “group” that immediately prior to such acquisition, beneficially owned fifty percent (50%) or more of the voting equity of the Company); (e) the replacement of a majority of the Company’s Board of Directors with individuals who were not nominated or elected by at least a majority of the directors at the time of such replacement; or (f) a transaction or series of transactions that constitutes or results in a “going private transaction” (as defined in Section 13(e) of the Exchange Act and the regulations of the Securities and Exchange Commission issued thereunder).

(e)“Common Stock” means (i) the Company’s Common Stock, $0.01 par value per share and (ii) any capital stock into which the Common Stock is changed or any capital stock resulting from a reclassification of the Common Stock.

(f)“Delivery Date” has the meaning attributed to it in Section 2(a).

(g)“Derivative Security” means any right, option, warrant or other security convertible into or exercisable for Common Stock.

(h)“Exchange Act” means the Securities Exchange Act of 1934, as amended.

(i)“Exercise Date” has the meaning attributed to it in Section 2(a).

(j)“Exercise Documents” has the meaning attributed to it in Section 2(a).

(k)“Exercise Notice” has the meaning attributed to it in Section 2(a).

(l)“Exercise Price” is equal to $0.01, subject to adjustment as set forth in this Warrant.

(m) “Expiration Date” means the seventh anniversary of the Issuance Date or, if such date falls on a day that is not a Business Day or a day on which trading does not take place on the principal exchange or automated quotation system on which the Common Stock is traded, the next Business Day.

(n)“Fully Diluted Basis” shall mean, at a given time, all shares of Common Stock of the Company issued and outstanding at such time, plus all such shares then issuable upon exercise of all then outstanding options, warrants and other convertible securities (including Class B Common Stock), whether or not such options, warrants or convertible securities are actually exercisable or convertible at such time, all calculated on an “as converted” to common stock basis.

(o)“Issuance Date” means ____________ _____, 20___.

(p)“Loan Agreement” has the meaning attributed to it in the preamble of this Warrant.

(q) “Payment” has the meaning attributed to it in Section 2(a)(ii).

(r)“Person” means a natural person or entity, or a government or any division, department or agency thereof.

(s)“Property Dividend” has the meaning attributed to it in Section 7(c).

(t)“Securities Act” means the Securities Act of 1933, as amended.

(u)“Warrant” means this Warrant and all Warrants issued in exchange, transfer or replacement thereof.

(v)“Warrant Shares” has the meaning attributed to it in the preamble of this Warrant.

Section 2.Exercise of Warrant.

(a)This Warrant may be exercised by the Holder registered on the books of the Company, in whole or in part, at any time prior to 11:59 p.m. Eastern Time on the Expiration Date. Any exercise of this Warrant shall be effected by:

(i)delivery of a written notice, in the form attached as Exhibit A (the “Exercise Notice”), of Holder’s election to exercise this Warrant, specifying the number of Warrant Shares to be purchased;

2

(ii)payment to the Company of an amount equal to the Exercise Price multiplied by the number of Warrant Shares being purchased (1) in cash or wire transfer of immediately available funds; (2) by means of a cashless exercise pursuant to Section 2(c); or (3) by surrender of all or a portion (as appropriate) of such Holder’s Common Stock pursuant to Section 2(d) (the foregoing methods set forth in (1) through (3) of this Section 2(a)(ii) referred to herein as the “Payment ,” and any Payment may include any combination of such methods); and

(iii) the surrender at the principal office of the Company or to a nationally recognized courier for overnight delivery to the Company, as soon as practicable following such date, of this Warrant, (or an indemnification undertaking with respect to this Warrant in the case of its loss, theft or destruction in such form and substance as reasonably satisfactory to the Company).

The Company shall, not later than the fifth Business Day (the “Delivery Date”) following receipt of an Exercise Notice, the Payment and this Warrant or such indemnification, as applicable (collectively, the “Exercise Documents”), arrange for its transfer agent, on or before the Delivery Date, to issue and surrender to a nationally recognized courier for overnight delivery to the address specified in the Exercise Notice, a certificate, registered in the name of the Holder or its designee, for the number of shares of Common Stockto which the Holder is entitled. Upon delivery of the Exercise Notice and the Payment (the “Exercise Date”), the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised on the Delivery Date, irrespective of the date of delivery of the certificates evidencing the Warrant Shares.

(b)Unless the rights represented by this Warrant have expired or been fully exercised, the Company shall, as soon as practicable and in no event later than five Business Days after receipt of the Exercise Documents and at its own expense, issue a new Warrant identical in all respects to this Warrant, except it shall represent rights to purchase the number of Warrant Shares purchasable immediately prior to exercise, less the number purchased.

(c)In lieu of or in addition to exercising this Warrant by means of paying via cash or wire transfer or pursuant to Section 2(d), the Holder may elect to make the Payment by means of receiving shares equal to the value of this Warrant (or portion thereof being exercised) by delivery and surrender of this Warrant together with the Exercise Notice in accordance with the terms hereof, duly completed to indicate a net issuance exercise and executed by the Holder, in which event the Company shall issue to the Holder a number of shares of Common Stock computed using the following formula:

X = Y(A-B)/A

Where X = the number of shares issued to the Holder;

Y = the number of shares purchasable (or portion thereof) under this Warrant that are being exercised at the date of the calculation;

A = the current market price of the Common Stock at the date of the calculation; and

B = the Exercise Price on the date of the calculation.

(d)In lieu of or in addition to exercising this Warrant by means of paying via cash or wire transfer or pursuant to Section 2(c), the Holder may elect to make the Payment by surrender of Common Stock. In such case, the Holder shall surrender the number of shares of Common Stock having an aggregate value computed at a per share value equal to the average of the volume weighted averages of the trading prices of the Common Stock, as such prices are reported on the NASDAQ Global Market (as reported by Bloomberg Financial Markets or such other source as the parties shall a gree in writing), for the ten consecutive trading days (“Fair Market Value”) ending on the second trading immediately preceding the date the Warrant is exercised (less any amounts paid via cash or wire transfer or pursuant to Section 2(c)). Unless all of the shares represented by the certificate for the Common Stock have been surrendered, the Company shall, as soon as practicable and in no event later than five Business Days after receipt of the Exercise Documents and at its own expense, issue a new certificate representing the remaining Common Stock owned by the Holder.

(e)No fractional shares of Common Stock are to be issued upon the exercise of this Warrant, but rather the number of shares of Common Stock issued shall be rounded up or down to the nearest whole number.

Section 3.Covenants. The Company hereby covenants and agrees as follows:

(a)This Warrant is, and any Warrants issued in substitution for or in replacement of this Warrant upon issuance will be, duly authorized, executed and delivered.

(b)All Warrant Shares upon issuance will be validly issued, fully paid and nonassessable and free from all liens and charges with respect to the issue thereof.

3

(c)As long as this Warrant may be exercised, the Company will have authorized and reserved at least the number of shares of Common Stock needed to provide for the exercise of the rights then represented by this Warrant.

Section 4.Warrant Holder Not Deemed a Stockholder. Except as specifically provided in Section 2(a), nothing contained in this Warrant shall be construed to (a) grant the Holder any rights to vote or receive dividends or be deemed the holder of shares of the Company for any purpose, (b) confer upon the Holder any of the rights of a stockholder of the Company or any right to vote, give or withhold consent to any corporate action (whether any reorganization, issue of stock, reclassification of stock, consolidation, merger, conveyance or otherwise), receive notice of meetings, receive dividends or subscription rights, or otherwise, or (c) impose any liabilities on the Holder to purchase any securities or as a stockholder of the Company, whether asserted by the Company or creditors of the Company, prior to the issuance of the Warrant Shares.

Section 5.Representations of Holder. The Holder, by the acceptance hereof, represents that it is acquiring this Warrant and the Warrant Shares for its own account for investment only and not with a view towards, or for resale in connection with, the public sale or distribution of this Warrant or the Warrant Shares, except pursuant to sales registered or exempted under the Securities Act. Upon exercise of this Warrant, the Holder shall, if requested by the Company, confirm in writing, in a form satisfactory to the Company, that the Warrant Shares are being acquired solely for the Holder’s own account and not as a nominee for any other party, for investment, and not with a view toward distribution or resale. If Holder cannot make such representations because they would be factually incorrect, it shall be a condition to Holder’s exercise of this Warrant that the Company receive such other representations as the Company considers reasonably necessary to assure the Company that the issuance of its securities upon exercise of this Warrant shall not violate any federal or state securities laws. The Company shall not be penalized or disadvantaged by a Holder’s inability to exercise this Warrant due to its inability to make the required representations in connection with the exercise of this Warrant.

Section 6.Ownership and Transfer.

(a)The Company shall maintain at its principal executive offices (or such other office or agency of the Company as it may designate by notice to the holder hereof), a register for this Warrant, in which the Company shall record the name and address of the Person in whose name this Warrant has been issued, as well as the name and address of each transferee who has acquired this Warrant in accordance with applicable law and the terms of this Warrant. The Company may treat the Person in whose name this Warrant is registered on the register as the owner and holder thereof for all purposes, notwithstanding any notice to the contrary, but in all events recognizing any transfers made in accordance with the terms of this Warrant.

(b)This Warrant may only be offered, sold, transferred or assigned in compliance with the Securities Act and applicable state securities laws. Any attempted transfer of this Warrant in violation of this Section 6(b) shall be null and void ab initio.

(c)Subject to the terms of this Section 6, upon surrender of this Warrant to the Company at its principal office or at the office of its transfer agent, if any, with the Assignment Form annexed hereto as Exhibit B duly executed and funds sufficient to pay any transfer tax, the Company shall, without charge, execute and deliver a new Warrant in the name of the assignee evidencing the portion of the Warrant certificate so transferred and a new Warrant certificate evidencing the remaining portion of the Warrant certificate not so transferred, if any, shall be issued to the transferring Holder. The delivery o f the new Warrant certificate by the Company to the transferee thereof shall be deemed to constitute acceptance by such transferee of all of the rights and obligations of a holder of a Warrant certificate. Subject to the terms of this Section 6, this Warrant may be divided or combined with other warrants which carry the same rights upon presentation hereof at the principal office of the Company together with a written notice specifying the names and denominations in which new Warrants are to be issued and signed by the Warrant Holder hereof.

Section 7.Adjustment of Exercise Price and Number of Shares. The Exercise Price and the number of Warrant Shares shall be adjusted from time to time as follows:

(a)Stock Splits. If the Company subdivides (by any stock split, recapitalization or otherwise) its outstanding shares of Common Stock into a greater number of shares, the Exercise Price in effect immediately prior to the subdivision will be proportionately reduced and the number of Warrant Shares will be proportionately increased. If the Company combines (by combination, reverse stock split or otherwise) its outstanding shares of Common Stock into a smaller number of shares, the Exercise Price in effect immediately prior to the combination will be proportionately increased and the number of Warrant Shares will be proportionately decreased. Any adjustment under this Section 7(a) shall become effective at the close of business on the date the subdivision or combination becomes effective.

(b)Stock Dividends. If the Company declares a dividend or any other distribution upon the Common Stock (other than the Rights Offering) that is payable in shares of Common Stock or Derivative Securities, the number of Warrant Shares will be proportionately increased and the Exercise Price in effect immediately prior to the declaration of the dividend or distribution will be reduced to the quotient obtained by dividing (i) the number of shares of Common Stock outstanding immediately prior to the declaration multiplied by the then effective Exercise Price by (ii) the total number of shares of Common Stock outstanding immediately after the declaration (assuming the exerci se or conversion of any such Derivative Securities for cash (not on a “cashless” basis)).

4

(c)Adjustment for Property Dividends. If the Company declares a dividend or any other distribution upon the Common Stock that is payable in any of its assets (including cash) or debt securities or any rights, options or warrants to purchase debt securities, assets or other securities of the Company (other than (i) Common Stock pursuant to which another provision of this Section 7 applies or (ii) any dividend or distribution upon a merger or consolidation or sale to which Section 8 applies) (a “Property Dividend”), then and in each such event the Exercise Price for this Warrant in effect immediately prior to the close of business on the date for the determination of the holders of Common Stock entitled to receive such dividend or distribution shall be decreased by the fair market value (as determined in good faith by the Board of Directors of the Company, whose determination shall be conclusive and evidenced by a Board Resolution filed with the Company) of such Property Dividend so distributed for each share of Common Stock.

Any adjustment under this Section 7(c) shall become effective immediately prior to the opening of business on the day after the date for the determination of the holders of Common Stock entitled to receive Property Dividend. If the Board of Directors determines the fair market value of any Property Dividend for purposes of this Section 7(c) by reference to the actual or when issued trading market for any securities comprising such Property Dividend, it must in doing so consider the prices in such market over the 30 days preceding the issuance of such Property Dividend.

For purposes of clarity, if a declared Property Dividend would have reduced the Exercise Price to an amount below $0, the Exercise Price will be reduced to $0 and any remaining fair market value of the Property Dividend that would have resulted in a reduction of the Exercise Price below $0 shall be reflected in an increase of the number of shares issuable upon exercise of this Warrant pursuant to Section 7(d) hereto.

(d)Adjustment for Property Dividend In Special Circumstances. In the event that the Exercise Price is or has been reduced to $0 or a price that rounds to $0 due to adjustments to the Exercise Price pursuant to Section 7(c) and the Company declares a dividend or any other distribution upon the Common Stock that is a Property Dividend, this Section 7(d) shall apply and the number of shares of Common Stock issuable upon exercise of the Warrant shall be adjusted in accordance with the formula:

N’ = N x        M       

                   M - F

Where N’ = the adjusted number of shares of Common Stock issuable upon exercise of this Warrant.

N = the current number of shares of Common Stock issuable upon exercise of this Warrant.

M = the Fair Market Value per share of Common Stock on the Business Day immediately preceding the ex date for such distribution.

F = the fair market value on the ex date for such distribution of the assets, securities, rights or warrants distributable to one share of Common Stock after taking into account, in the case of any rights, options or warrants, the consideration required to be paid upon exercise thereof. The Board of Directors of the Company shall reasonably determine the fair market value in good faith.

The adjustment shall be made successively whenever any such distribution is made and shall become effective immediately after the record date for the determination of stockholders entitled to receive such distribution.

This Section 7(d) does not apply to regular quarterly cash dividends. If any adjustment is made pursuant to this Section 7(d) as a result of the issuance of rights, options or warrants and at the end of the period during which any such rights, options or warrants are exercisable, not all such rights, options or warrants shall have been exercised, this Warrant shall be immediately readjusted as if “F” in the above formula was the fair market value on the ex date for such distribution of the indebtedness or assets actually distributed upon exercise of such rights, options or warrants divided by the number of shares of Common Stock outstanding on the ex-dividend date for such distribution. Not withstanding anything to the contrary contained in this Section 7(d), if “M-F” in the above formula is less than $1.00, the Company may elect to, and if “M-F” or is a negative number, the Company shall, in lieu of the adjustment otherwise required by this Section 7(d), distribute to the holder of this Warrant, upon exercise thereof, the evidences of indebtedness, assets, rights, options or warrants (or the proceeds thereof) which would have been distributed to such holder had this Warrant been exercised (for cash) immediately prior to the record date for such distribution.

“ex date” means the first date on which Common Stock trades in a regular wayon the relevant exchange or in the relevant market from which the quoted price was obtained without the right to receive such issuance or distribution.

5

“Trading Day” means each Monday, Tuesday, Wednesday, Thursday and Friday, other than any day on which securities are not traded on the applicable securities exchange or in the applicable securities market.

(e)Other Adjustments.

(i) Notwithstanding anything to the contrary contained in this Section 7, if, at any time while this Warrant is outstanding, the Company shall issue or sell shares of Common Stock, or Derivative Securities to someone other than the Holder, at a price per share (determined, in the case of such Derivative Securities, by dividing (A) the total amount receivable by the Company in consideration of the issuance and sale of such Derivative Securities, plus the total consideration, if any, payable to the Company upon exercise, conversion or exchange thereof, by (B) the total number of shares of Common Stock covered by such Derivative Securities) that is lower than the Ex ercise Price, the Company shall adjust the Exercise Price and number of shares into which this Warrant is convertible so that this Warrant shall be exercisable for the same percentage of the outstanding Common Stock (on an “as converted” basis) following the issuance or sale of such other shares of Common Stock or Derivative Securities for the same aggregate consideration prior to such adjustment; provided, that such adjustments shall only be made for the benefit of the Holder of this Warrant.

(ii)Notwithstanding anything to the contrary contained in this Section 7, if, at any time while this Warrant is outstanding, the number of shares underlying any Derivative Security, and/or the exercise or conversion price of such Derivative Security adjusts or would have adjusted for any reason (including as a result of the issuance of this Warrant) and the terms, manner or method of such adjustment are more favorable than the adjustment provisions contained in this Section 7, the Company shall adjust the Exercise Price and/or number of shares into which this Warrant is convertible in order to give the H older the benefit of the more favorable terms, manner and/or method; provided, that no adjustment shall be made pursuant to this Section 7(e)(ii): (A) if an adjustment is otherwise required pursuant to another provision contained in this Section 7; or (B) if the additional adjustment that may be required by this Section 7(e)(ii) would not require a decrease or increase of at least 1% in the Exercise Price then in effect or the number of Warrant Shares for which this Warrant is then exercisable.  For the avoidance of doubt, the Exercise Price and number of Warrant Shares issuable shall be adjusted so that this Warrant shall be exercisable for the same percentage of the outstanding Common Stock (on a fully diluted basis) following the adjustment of such other Derivative Security pursuant to the foregoing sentence for the same aggregate consideration prior to such adjustment; provided, that following such adjustment, if the exercise price of such other Derivate Security is less than the Exercise Price, the Exercise Price shall be reduced to the same exercise price as the Derivative Security; provided further, that such adjustments shall only be made for the benefit of the Holder of this Warrant.

Section 8.Purchase Rights; Reorganization, Reclassification, Consolidation, Merger or Sale. Upon the consummation of any (i) sale of all or substantially all of the Company’s assets to an acquiring Person or (ii) other Change of Control following which the Company is not a surviving entity, the Company will secure from the Person purchasing the assets or the successor resulting from the Change of Control (in each case, the “Acquiring Entity”) a written agreement to deliver to Holder in exchange for this Warrant, a security of the Acquiring Entity evidenced by a written instrument substantially sim ilar in form and substance to this Warrant and reasonably satisfactory to the Holder. Prior to the consummation of any other Change of Control, the Company shall make appropriate provision to insure that Holder will thereafter have the right to acquire and receive in lieu of the shares of Common Stock immediately theretofore acquirable and receivable upon the exercise of this Warrant, such shares of stock, securities or assets that would have been issued or payable in the Change of Control with respect to or in exchange for the number of Warrant Shares that would have been acquirable as of the date of the Change of Control.

Section 9.Lost, Stolen, Mutilated or Destroyed Warrant. If this Warrant is lost, stolen, mutilated or destroyed, the Company shall promptly, on receipt of an indemnification undertaking reasonably satisfactory to the Company (or, in the case of a mutilated Warrant, the Warrant), issue a new Warrant of like denomination and tenor as this Warrant so lost, stolen, mutilated or destroyed.

Section 10.Notice. Any notices, consents, waivers or other communications required or permitted to be given under the terms of this Warrant must be in writing and will be deemed to have been delivered: (i) upon receipt, when delivered personally; (ii) upon receipt, when sent by fax transmittal (provided confirmation of transmission is mechanically or electronically generated and kept on file by the sending party); or (iii) one Business Day after deposit with a nationally recognized overnight delivery service, in each case properly addressed to the party to receive the same. The addresses and fax numbers for commun ications shall be:

If to the Company:

BioFuel Energy Corp.

1625 Broadway, Suite 2400

Denver, CO 80202

Tel: [____________]

Fax: [____________]

Attention: President

6

With a copy to:

Cravath, Swaine & Moore, LLP

Worldwide Plaza

825 Eight Avenue

New York, NY 10019-7475

Tel: (212) 474-1024

Fax: (212) 474-3700

Attention: Craig F. Arcella

If to the Holder, at the address and fax number set forth on Appendix I to this Warrant. Each party shall provide five days’ prior written notice to the other party of any change in address or fax number. Written confirmation of receipt (A) given by the recipient of any notice, consent, waiver or other communication, (B) mechanically or electronically generated by the sender’s fax machine containing the time, date, recipient fax number and an image of the first page of the transmission, or (C) provided by a nationally recognized overnight delivery service, shall be rebuttable evidence of receipt.

Section 11.Amendment and Waiver. Except as otherwise provided herein, this Warrant may not be modified or amended except pursuant to an instrument in writing signed by the Company and the Holder. No provision hereunder may be waived other than in a written instrument executed by the waiving party.

Section 12.Governing Law. This Warrant shall be construed and enforced in accordance with, and all questions concerning the construction, validity, interpretation and performance of this Warrant shall be governed by, the internal laws of the State of Delaware, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of Delaware or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of Delaware.

Section 13.Restrictive Legends. At all times this Warrant and until such time as a registration statement has been declared effective by the U.S. Securities and Exchange Commission or the Warrant Shares may be sold pursuant to Rule 144 under the Securities Act without any restriction as to the number of securities that can then be immediately sold, certificates for any Warrant Shares will, in addition to any legend required under applicable securities law, bear a restrictive legend substantially in the form first set forth above.

IN WITNESS WHEREOF, the Company has caused this Warrant to be signed as of , __________ ___, 20___.

BIOFUEL ENERGY CORP.

By:           

                                                                                                                                             & #160;   Name:

                                                                                                                                             & #160;   Title:

7 

Exhibit A To Warrant

BIOFUEL ENERGY CORP.

EXERCISE NOTICE

TO BE EXECUTED BY THE REGISTERED HOLDER

TO EXERCISE THIS WARRANT

The undersigned holder hereby exercises the right to purchase shares of Common Stock (“Warrant Shares”) of BioFuel Energy Corp., a Delaware corporation (the “Company”), evidenced by the attached Warrant (the “Warrant”). Capitalized terms used herein and not otherwise defined shall have the respective meanings set forth in the Warrant.

1.      Payment of Exercise Price (check applicable box).

Payment in the sum of $ [is enclosed] [has been wire transferred to the Company at the following account:] in accordance with the terms of the Warrant.

Holder hereby elects to make the Payment for the Warrant Shares in accordance with Section 2(c) of the Warrant.

Holder hereby elects to make the Payment for the Warrant Shares in accordance with Section 2(d) of the Warrant.

Number of shares of Common Stock surrendered _______________:

2.      Delivery of Warrant Shares. The Company shall deliver the Warrant Shares in the name of the undersigned or in such other name as is specified below in accordance with Section 2(a) of the Warrant at the following address:

3.      Accredited Investor. The undersigned is an “accredited investor” as defined in Regulation D promulgated under the Securities Act of 1933, as amended.

Date: ____________ ___, _____

By:                                                                                                                                      &# 160;                    

                 Name:

                 Title:

ACKNOWLEDGMENT

The Company hereby acknowledges this Exercise Notice and hereby directs _______________ to issue the above indicated number of shares of Common Stock in accordance with the Transfer Agent Instructions dated __________ ___, 20___ from the Company and acknowledged and agreed to by _______________.

BIOFUEL ENERGY CORP.

By:          

                                                                                                                                             & #160;  Name:

                                                                                                                                             & #160;  Title:

Exhibit B To Warrant

ASSIGNMENT

To be Executed by the Registered Holder in Order to Assign Warrants

For Value Received, _____________________________________________________ hereby sells, assigns and transfers unto

(PLEASE TYPE OR PRINT NAME AND ADDRESS)

(SOCIAL SECURITY OR TAX IDENTIFICATION NUMBER)

and be delivered to                                                                                                                                    0;                                                                                                                                                                          & #160;                     

(PLEASE PRINT OR TYPE NAME AND ADDRESS)

____________________ of the Warrants represented by this Warrant Certificate and does hereby irrevocably constitute and appoint ____________________ Attorney to transfer this Warrant Certificate on the books of the Company, with full power of substitution in the premises.

Dated:                                                                                                                                                                          

                                                                                                                                             & #160;  (SIGNATURE)

THE SIGNATURE TO THE ASSIGNMENT MUST CORRESPOND TO THE NAME WRITTEN UPON THE FACE OF THIS WARRANT CERTIFICATE IN EVERY PARTICULAR, WITHOUT ALTERATION OR ENLARGEMENT OR ANY CHANGE WHATSOEVER AND MUST BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM PURSUANT TO S.E.C. RULE 17 Ad – 15).

Appendix I

Holder’s Contact Information

Name:   

Address:   

City, State, Zip:   

Telephone Number:   

Facsimile Number:   

E-mail Address:   

-----END PRIVACY-ENHANCED MESSAGE-----